ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2021

A Target HbA1c Between 7 and 7.7% Reduces Microvascular and Macrovascular Events in T2D Regardless of Duration of Diabetes: a Meta-Analysis of Randomized Controlled Trials.

Binayak Sinha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.